Ping-Yen Liu – 國立成功大學-臨床醫學研究所

Professor Ping-Yen Liu is an internationally recognized cardiovascular specialist and Distinguished Professor at the College of Medicine, National Cheng Kung University (NCKU), and its affiliated hospital. Trained in vascular pharmacology at Harvard Medical School, he is dedicated to translational medicine, transforming frontline clinical insights into impactful therapeutic strategies.

His expertise encompasses vascular biology, heart failure, and AI-driven precision medicine. He has extensive experience in cardiovascular risk stratification and innovative diagnostic approaches that integrate clinical insight with advanced analytics.

Professor Liu has published widely in leading international journals and translated his research into clinical patents and award-winning innovations. Committed to addressing unmet clinical needs, he advances intelligent healthcare platforms while mentoring the next generation of biomedical scientists. His work exemplifies the integration of clinical excellence, academic leadership, and technological innovation in modern cardiovascular medicine.

Professor Liu is a Distinguished Professor at National Cheng Kung University and a recipient of the “Research Hall of Fame” honor from the Department of Internal Medicine at NCKU Hospital. He has demonstrated exceptional translational research excellence, earning the National Innovation Advancement Award for two consecutive terms and being repeatedly ranked first in the Department’s Best Research Award (Professor Category).

He has also been recognized as a Distinguished Alumnus of Kaohsiung Medical University. In addition to his research achievements, Professor Liu is deeply committed to education and mentorship, guiding numerous students to receive major national awards in academic research competitions.

Current Positions

President, Taiwan Society of Lipids and Atherosclerosis (Oct 2024–Present)
Chair, Department of Internal Medicine, National Cheng Kung University Hospital (Aug 2023–Present)
Distinguished Professor, Institute of Clinical Medicine, National Cheng Kung University (Aug 2023–Present)
Attending Cardiologist, Division of Cardiology, National Cheng Kung University Hospital (Aug 2000–Present)

Selected Previous Appointments

Director, Institute of Clinical Medicine, National Cheng Kung University (Aug 2020–Jul 2023)
Convener, Cardiovascular Research Section, National Science and Technology Council (Jan 2020–Dec 2020)

近期學術重要著作:

Hsu YL, Lee CH, Chung WP, Lee WH, Lee KT, Tsai JH, Hsu HP, Yang SR, Loh ZJ, Su PF, Hung CM, Tsai WC, Liu YW, Liu PY*. Primary cardioprotective effect of sacubitril/valsartan in breast cancer patients receiving adjuvant therapy. European Journal of Heart Failure 2025/07.
Lee PT, Huang MH, Huang TC, Sung PS, Hsu CH, Huang YL, Lin SH, Liu PY*. Improvement of Oral Anticoagulant Prescription and Long-Term Clinical Outcomes of Patients With Atrial Fibrillation After Implementation of a Clinical Decision Support System in Outpatient Practice. Journal of the American Heart Association 2025/08.
Vairaperumal T, Lee PT, Liu PY*. Portable Point-of-Care Diagnosis Platforms and Emerging Predictive Biomarkers for Rapid Detection of Severe Dengue Viral Infection. ACS Sensors 2025/05.
Chen PW, Tseng BY, Yang ZH, Yu CH, Lin KT, Chen JN, Liu PY*. Deep learning model for diagnosis of venous thrombosis from lower extremity peripheral ultrasound imaging. iScience 2024/11.
Chang HY, Hsu HC, Fang YH, Liu PY*, Liu YW. Empagliflozin attenuates doxorubicin-induced cardiotoxicity by inhibiting the JNK signaling pathway. Biomedicine & Pharmacotherapy 2024/07.
Lee PT, Huang MH, Huang TC, Hsu CH, Lin SH, Liu PY*. High Burden of Premature Ventricular Complex Increases the Risk of New-Onset Atrial Fibrillation. Journal of the American Heart Association 2023/02.
Chen PW, Lee CH, Liu PY*. Sex Difference in Bleeding Risk With P2Y12 Inhibitor Agents After Percutaneous Coronary Intervention. JAMA Cardiology 2022/03.
Sitjar J, Liao JD, Lee H, Tsai HP, Wang JR, Liu PY*. Challenges of SERS technology as a non-nucleic acid or -antigen detection method for SARS-CoV-2 virus and its variants. Biosensors and Bioelectronics 2021/06.
Liu YW, Huang MS, Hsu LW, Chang HY, Lee CH, Lee CY, Chen DP, Li YH, Chao TH, Su PF, Shen MR, Liu PY*. Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents. iScience 2021/09.
Liu PY, Tsai YS, Chen PL, Tsai HP, Hsu LW, Wang CS, Lee NY, Huang MS, Wu YC, Ko WC, Yang YC, Chiang JH, Shen MR. Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients With SARS-CoV-2 at a Smart Quarantine Station: Observational Study. Journal of Medical Internet Research 2020/10.

專書:

Ping-Yen Liu, Tharmaraj Vairaperumal, Devi Selvaraj: Point-of-Care Technology for Portable Testing Devices. 2025/06; Paperback ISBN: 9780443330308